Migration of cytotoxic T lymphocytes toward melanoma cells in three-dimensional organotypic culture is dependent on CCL2 and CCR4 - PubMed (original) (raw)
Migration of cytotoxic T lymphocytes toward melanoma cells in three-dimensional organotypic culture is dependent on CCL2 and CCR4
Tianqian Zhang et al. Eur J Immunol. 2006 Feb.
Free article
Abstract
Studies in experimental animal models have demonstrated that chemokines produced by tumor cells attract chemokine receptor-positive T lymphocytes into the tumor area. However, in cancer patients, the role of chemokines in T lymphocyte trafficking toward human tumor cells is relatively unexplored. In the present study, the migration of a melanoma patient's CTL toward autologous tumor cells has been studied in a novel three-dimensional organotypic melanoma culture. In this model, CTL migrated toward tumor cells, resulting in tumor cell apoptosis. CTL migration was mediated by the CC chemokine receptor (CCR)4 expressed by the CTL and the CC chemokine ligand (CCL)2 secreted by the tumor cells, as evidenced by blockage of CTL migration by CCL2 or antibodies to CCL2 or CCR4. These results were confirmed in a Transwell migration assay in which the CTL actively migrated toward isolated CCL2 and migration was inhibited by anti-CCR4 antibody. These studies, together with previous studies in mice indicating regression of CCL2-transduced tumor cells, suggest that CCL2 may be useful as an immunotherapeutic agent for cancer patients.
Similar articles
- CXC chemokine ligand 12 (stromal cell-derived factor 1 alpha) and CXCR4-dependent migration of CTLs toward melanoma cells in organotypic culture.
Zhang T, Somasundaram R, Berencsi K, Caputo L, Rani P, Guerry D, Furth E, Rollins BJ, Putt M, Gimotty P, Swoboda R, Herlyn M, Herlyn D. Zhang T, et al. J Immunol. 2005 May 1;174(9):5856-63. doi: 10.4049/jimmunol.174.9.5856. J Immunol. 2005. PMID: 15843590 - Colon carcinoma cells induce CXCL11-dependent migration of CXCR3-expressing cytotoxic T lymphocytes in organotypic culture.
Berencsi K, Meropol NJ, Hoffman JP, Sigurdson E, Giles L, Rani P, Somasundaram R, Zhang T, Kalabis J, Caputo L, Furth E, Swoboda R, Marincola F, Herlyn D. Berencsi K, et al. Cancer Immunol Immunother. 2007 Mar;56(3):359-70. doi: 10.1007/s00262-006-0190-2. Epub 2006 Jun 17. Cancer Immunol Immunother. 2007. PMID: 16783574 Free PMC article. - Potential involvement of monocyte chemoattractant protein (MCP)-1/CCL2 in IL-4-mediated tumor immunity through inducing dendritic cell migration into the draining lymph nodes.
Wang H, Nemoto-Sasaki Y, Kondo T, Akiyama M, Mukaida N. Wang H, et al. Int Immunopharmacol. 2003 May;3(5):627-42. doi: 10.1016/S1567-5769(02)00251-5. Int Immunopharmacol. 2003. PMID: 12757733 - CCL2 (monocyte chemoattractant protein-1) and cancer.
Conti I, Rollins BJ. Conti I, et al. Semin Cancer Biol. 2004 Jun;14(3):149-54. doi: 10.1016/j.semcancer.2003.10.009. Semin Cancer Biol. 2004. PMID: 15246049 Review. - Antagonists of CCR4 as immunomodulatory agents.
Purandare AV, Somerville JE. Purandare AV, et al. Curr Top Med Chem. 2006;6(13):1335-44. doi: 10.2174/15680266106061335. Curr Top Med Chem. 2006. PMID: 16918452 Review.
Cited by
- Chemokines and Cytokines in Immunotherapy of Melanoma and Other Tumors: From Biomarkers to Therapeutic Targets.
Reschke R, Enk AH, Hassel JC. Reschke R, et al. Int J Mol Sci. 2024 Jun 13;25(12):6532. doi: 10.3390/ijms25126532. Int J Mol Sci. 2024. PMID: 38928238 Free PMC article. Review. - E2F2 stimulates CCR4 expression and activates synovial fibroblast-like cells in rheumatoid arthritis.
Xu W, Li S, Chang X. Xu W, et al. Cent Eur J Immunol. 2021;46(1):27-37. doi: 10.5114/ceji.2021.105243. Epub 2021 Apr 18. Cent Eur J Immunol. 2021. PMID: 33897281 Free PMC article. - MicroRNA-206 promotes the recruitment of CD8+ T cells by driving M1 polarisation of Kupffer cells.
Liu N, Wang X, Steer CJ, Song G. Liu N, et al. Gut. 2022 Aug;71(8):1642-1655. doi: 10.1136/gutjnl-2021-324170. Epub 2021 Oct 27. Gut. 2022. PMID: 34706869 Free PMC article. - ELF-1 expression in nasopharyngeal carcinoma facilitates proliferation and metastasis of cancer cells via modulation of CCL2/CCR2 signaling.
Chen CH, Su LJ, Tsai HT, Hwang CF. Chen CH, et al. Cancer Manag Res. 2019 Jun 6;11:5243-5254. doi: 10.2147/CMAR.S196355. eCollection 2019. Cancer Manag Res. 2019. PMID: 31289447 Free PMC article. - Targeting the CCL2/CCR2 Axis in Cancer Immunotherapy: One Stone, Three Birds?
Fei L, Ren X, Yu H, Zhan Y. Fei L, et al. Front Immunol. 2021 Nov 3;12:771210. doi: 10.3389/fimmu.2021.771210. eCollection 2021. Front Immunol. 2021. PMID: 34804061 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical